{"organizations": [], "uuid": "d8e0136addbb365f6c0a469c9a73d83033b2c377", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://www.reuters.com/resources/archive/us/20180214.html", "section_title": "Archive News &amp; Video for Wednesday, 14 Feb 2018 | Reuters.com", "url": "https://www.reuters.com/article/brief-tianjin-tianyao-pharmaceuticals-si/brief-tianjin-tianyao-pharmaceuticals-signs-two-api-technical-development-commission-contracts-worth-3-mln-yuan-idUSL4N1Q42SJ", "country": "US", "domain_rank": 408, "title": "BRIEF-Tianjin Tianyao Pharmaceuticals signs two API technical development commission contracts worth 3 mln yuan", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-02-14T14:21:00.000+02:00", "replies_count": 0, "uuid": "d8e0136addbb365f6c0a469c9a73d83033b2c377"}, "author": "Reuters Editorial", "url": "https://www.reuters.com/article/brief-tianjin-tianyao-pharmaceuticals-si/brief-tianjin-tianyao-pharmaceuticals-signs-two-api-technical-development-commission-contracts-worth-3-mln-yuan-idUSL4N1Q42SJ", "ord_in_thread": 0, "title": "BRIEF-Tianjin Tianyao Pharmaceuticals signs two API technical development commission contracts worth 3 mln yuan", "locations": [], "entities": {"persons": [], "locations": [], "organizations": [{"name": "tianjin pharmaceuticals re", "sentiment": "negative"}, {"name": "brief-tianjin tianyao pharmaceuticals", "sentiment": "negative"}, {"name": "reuters) - tianjin tianyao pharmaceuticals co ltd", "sentiment": "neutral"}, {"name": "beijing headline news", "sentiment": "none"}, {"name": "ltd", "sentiment": "none"}, {"name": "institute co.", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "Feb 14 (Reuters) - Tianjin Tianyao Pharmaceuticals Co Ltd :\n* Says it and Tianjin Pharmaceuticals Research Institute Co., Ltd signs two technical development commission contracts of API glycyl-glutamine and glycyltyrosine worth 3 million yuan\nSource text in Chinese: goo.gl/WMG4QE\nFurther company coverage: (Beijing Headline News)\n ", "external_links": ["https://goo.gl/WMG4QE", "http://thomsonreuters.com/en/about-us/trust-principles.html"], "published": "2018-02-14T14:21:00.000+02:00", "crawled": "2018-02-15T20:46:28.011+02:00", "highlightTitle": ""}